相关实验视频

Updated: May 25, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

目前在肺癌治疗中治疗疫苗的发展

Jesus Salvador Flores Banda¹, Sanjana Gangane¹, Fatima Raza¹

¹Department of Medicine, University of Texas at Tyler School of Medicine, 11937 US Hwy 271, Tyler, TX 75799, USA.

|February 26, 2025

概括

癌症疫苗为肺癌提供了一个有前途的免疫治疗方法. 早期招募和向新瘤新抗原是克服非小细胞肺癌 (NSCLC) 和小细胞肺癌 (SCLC) 挑战的关键.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
疫苗开发疫苗开发

背景情况:

癌症疫苗利用免疫系统准瘤细胞,呈现出一种新的免疫疗法策略.
肺癌疫苗在早期试验中显示出潜力,但面临着瘤耐药性和异质性等挑战.

研究的目的:

审查目前和正在进行的肺癌疫苗临床试验.
分析不同的疫苗开发策略及其相关挑战.
讨论癌症疫苗在治疗非小细胞肺癌 (NSCLC) 和小细胞肺癌 (SCLC) 的潜力.

主要方法:

对肺癌疫苗的已完成和正在进行的临床试验的审查.
分析疫苗策略,包括新抗原鉴定.
讨论诸如瘤异质性和免疫逃避等挑战.

主要成果:

早期试验表明,肺癌疫苗接种改善了生存率.
了解免疫系统和疫苗技术的进步提高了治疗潜力.
在晚期癌症和瘤抵抗机制方面,挑战仍然存在.

结论:

肺癌的疫苗开发,包括NSCLC和SCLC,显示出希望,但需要进一步的研究.
针对早期疾病和新瘤新抗原的向对于未来的成功至关重要.
克服免疫逃避和瘤异质性仍然是有效的癌症疫苗接种的重大障碍.

关键词:

临床试验是指临床试验中的临床试验.肺癌是一种肺癌.非小细胞肺癌的肺癌.小细胞肺癌是一种小细胞肺癌.治疗癌症的疫苗,治疗癌症的疫苗.

更多相关视频

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...